NO20022599L - Klorofyll- og bakterioklorofyllestere, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike - Google Patents

Klorofyll- og bakterioklorofyllestere, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike

Info

Publication number
NO20022599L
NO20022599L NO20022599A NO20022599A NO20022599L NO 20022599 L NO20022599 L NO 20022599L NO 20022599 A NO20022599 A NO 20022599A NO 20022599 A NO20022599 A NO 20022599A NO 20022599 L NO20022599 L NO 20022599L
Authority
NO
Norway
Prior art keywords
sub
sup
coxr
chlorophyll
bacteriochlorophyll
Prior art date
Application number
NO20022599A
Other languages
English (en)
Other versions
NO20022599D0 (no
NO323208B1 (no
Inventor
Hugo Scheer
Nina Kammhuber
Avigdor Scherz
Alexander Brandis
Yoram Salomon
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20022599D0 publication Critical patent/NO20022599D0/no
Publication of NO20022599L publication Critical patent/NO20022599L/no
Publication of NO323208B1 publication Critical patent/NO323208B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
NO20022599A 1999-12-01 2002-05-31 Omforestringsfremgangsmate for fremstilling av klorofyll- og bakterioklorofyll-C13(3), C-17(3) diestere NO323208B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13325399A IL133253A0 (en) 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
PCT/IL2000/000811 WO2001040232A1 (en) 1999-12-01 2000-12-01 Chlorophyll and bacteriochlorophyll esters, and their preparation

Publications (3)

Publication Number Publication Date
NO20022599D0 NO20022599D0 (no) 2002-05-31
NO20022599L true NO20022599L (no) 2002-07-11
NO323208B1 NO323208B1 (no) 2007-01-22

Family

ID=11073554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022599A NO323208B1 (no) 1999-12-01 2002-05-31 Omforestringsfremgangsmate for fremstilling av klorofyll- og bakterioklorofyll-C13(3), C-17(3) diestere

Country Status (18)

Country Link
US (1) US7169753B2 (no)
EP (1) EP1246826B1 (no)
JP (1) JP2003515538A (no)
CN (1) CN1222526C (no)
AT (1) ATE308545T1 (no)
AU (1) AU777761B2 (no)
BR (1) BR0016051A (no)
CA (1) CA2392989A1 (no)
DE (1) DE60023748T2 (no)
DK (1) DK1246826T3 (no)
ES (1) ES2250214T3 (no)
HU (1) HU224553B1 (no)
IL (1) IL133253A0 (no)
MX (1) MXPA02005455A (no)
NO (1) NO323208B1 (no)
PL (1) PL356391A1 (no)
RU (1) RU2250905C2 (no)
WO (1) WO2001040232A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
AU2003230164B2 (en) 2002-05-08 2008-05-01 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
ES2572976T3 (es) 2003-07-31 2016-06-03 Gentlewaves Llc Sistema y método para el tratamiento fotodinámico de la piel
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
DK1753457T3 (en) * 2004-06-07 2016-12-05 Yeda Res & Dev Cationic bakterieklorofylderivater and uses
JP2008501727A (ja) 2004-06-09 2008-01-24 キュー エル ティー インク． 外用塗布した疎水性緑色ポルフィリンを用いた機能亢進性皮脂腺障害を治療するための光線力学的療法
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
RU2303966C2 (ru) * 2005-10-11 2007-08-10 Федеральное Государственное Учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию Способ снижения поверхностной дозы офтальмоаппликатора при проведении брахитерапии внутриглазных новообразований
RU2345803C2 (ru) * 2006-11-30 2009-02-10 Закрытое Акционерное Общество "Исследовательские лаборатории "РАДА-ФАРМА" Способ фотоиммунотерапии фотосенсибилизатором, активируемым волновой энергией вне организма человека
RU2336917C1 (ru) * 2007-05-29 2008-10-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУДПО РМАПО Росздрава) Способ лечения больных псориазом
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
FR2924021B1 (fr) * 2007-11-27 2010-08-13 Du Vernet Michele Eymard Composition pour le traitement de la peau par therapie photodynamique
EP2244787A1 (en) * 2008-01-28 2010-11-03 Yeda Research And Development Company Ltd. Endoscopic imaging photodynamic therapy system and methods of use
CA2717060C (en) 2008-02-27 2016-11-01 Avigdor Scherz Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
BR112013017953A2 (pt) 2011-01-13 2017-08-29 Quadra Logic Tech Inc Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
IN2014CN02153A (no) * 2011-08-23 2015-05-29 Yeda Res & Dev
CN104703624A (zh) 2012-07-11 2015-06-10 德米拉股份有限公司 局部递送光敏剂的药物组合物及其应用
US10117942B2 (en) 2013-07-12 2018-11-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery
RU2021110230A (ru) 2016-04-10 2021-05-26 Йеда Рисерч Энд Дивелопмент Ко. Лтд. Комбинированные способы терапии для лечения злокачественной опухоли
CN108341827A (zh) * 2018-02-02 2018-07-31 浙江海正药业股份有限公司 一种制备脱镁细菌叶绿素a及脱镁细菌叶绿素a酯的方法
CN108191877A (zh) * 2018-02-05 2018-06-22 云南瑞宝生物科技股份有限公司 一种从蚕沙中提取和纯化叶绿素的方法
US12178907B2 (en) 2018-07-12 2024-12-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same
CN111171030B (zh) * 2018-11-12 2022-11-22 浙江海正药业股份有限公司 细菌叶绿素衍生物及其制备方法
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU857139A1 (ru) * 1979-11-02 1981-08-23 Предприятие П/Я В-2343 Способ получени порфиринов,содержащих изоциклическое метилциклопентановое кольцо
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
DE4121867A1 (de) 1991-07-02 1993-01-07 Leifeld & Lemke Maschf Vorrichtung zur pruefung der dichtigkeit von mit deckeln luftdicht verschlossenen bechern
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
PL356391A1 (pl) 2004-06-28
BR0016051A (pt) 2002-07-23
DK1246826T3 (da) 2006-01-02
US20030148926A1 (en) 2003-08-07
IL133253A0 (en) 2001-04-30
HUP0204167A3 (en) 2004-08-30
RU2250905C2 (ru) 2005-04-27
EP1246826B1 (en) 2005-11-02
CN1425015A (zh) 2003-06-18
NO20022599D0 (no) 2002-05-31
JP2003515538A (ja) 2003-05-07
CA2392989A1 (en) 2001-06-07
US7169753B2 (en) 2007-01-30
WO2001040232A1 (en) 2001-06-07
EP1246826A1 (en) 2002-10-09
HUP0204167A2 (hu) 2003-03-28
WO2001040232A9 (en) 2002-09-12
MXPA02005455A (es) 2002-11-29
NO323208B1 (no) 2007-01-22
HU224553B1 (hu) 2005-10-28
AU777761B2 (en) 2004-10-28
DE60023748D1 (de) 2005-12-08
ATE308545T1 (de) 2005-11-15
HK1056557A1 (en) 2004-02-20
DE60023748T2 (de) 2006-08-03
CN1222526C (zh) 2005-10-12
ES2250214T3 (es) 2006-04-16
AU1729201A (en) 2001-06-12

Similar Documents

Publication Publication Date Title
NO20022599D0 (no) Klorofyll- og bakterioklorofyllesteres, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike
CY1121447T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
ES2136673T3 (es) Utilizacion del factor de crecimiento de los queratinocitos para la obtencion de medicamentos.
GEP20022804B (en) Erythropoietin Derivatives
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
EP1226109A4 (en) PHENYLAMINE CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DISPENSING ACTIVE AGENTS
CA2293470A1 (en) Benzimidazole derivatives
DE60012557D1 (de) Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
DK0661987T3 (da) Morphogeninduceret leverregeneration
RU95110937A (ru) Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
DK1007566T3 (da) Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
ATE426402T1 (de) Medizinische zusammensetzungen enthaltend 2-amino-2-a2-(4-octylphenyl)ethylupropan-1,3-di l
ITRM970238A0 (it) Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella terapia di patologie corneali e congiuntivali
RU2007129266A (ru) Фармацевтический состав для профилактики рака и для борьбы с ним
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
PT941110E (pt) Utilizacao do factor 2 de crescimento dos ceratinocitos
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
AU2002333535A1 (en) Treatment of excessive radiation (e.g. sunburn) exposure
AU2018363797A1 (en) Composition for the treatment of intracellular bacterial infection
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
CY1108761T1 (el) Απενεργοποιημενες κυτοκινες για ανοσοποιηση
FI972121A0 (fi) Sammansaettningar foer reciprok oekning av immunosupperssanters och interferoners farmaceutiska aktiviteter